Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003) : 4·5-year results from a phase 3, randomised, double-blind, placebo-controlled trial.

Tricou V, Yu D, Reynales H, et al. Lancet Glob Health. 2024；12：e257-70.

RSV Prefusion F Protein–Based Maternal Vaccine—Preterm Birth and Other Outcomes.

Dieussaert I, Hyung Kim J, Luik S, et al. N Engl J Med. 2024；390：1009-21.

COVID-19 Vaccination and Incidence of Pediatric SARS-CoV-2 Infection and Hospitalization.

Head JR, Collender PA, León TM, et al. JAMA Netw Open. 2024；7：e247822.

Epidemiological and clinical insights into the enterovirus D68 upsurge in Europe 2021–22 and the emergence of novel B3-derived lineages, ENPEN multicentre study.

Simoes MP, Hodcro EB, Simmonds P, et al. J Infect Dis. 2024；230：e917–28.

Clinical, microbiological, and molecular characterization of pediatric invasive infections by Streptococcus pyogenes in Spain in a context of global outbreak.

Ramírez de Arellano E, Saavedra-Lozano J, Villalón P, et al. mSphere. 2024；9：e0072923.

The impact of EV71 vaccination program on hand, foot and mouth disease in Zhejiang Province, China: A negative control study.

Zheng D, Shen L, Wen W, et al. Infect Dis Model. 2023；8：1088-96.